White label ELPA - ClinicalTrials.eu

Study on the Effect of Salbutamol on Walking Ability in Patients with ALS

Not recruiting

2 1 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
Investigated Drugs:
- Salbutamol Sulfate
Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Lebrikizumab
Study on Ketotifen Eye Drops for Treating Seasonal Allergic Conjunctivitis in Patients

Not recruiting

3 1 1
Investigated Diseases:
- Conjunctivitis allergic
Investigated Drugs:
- Ketotifen Hydrogen Fumarate
Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

Not recruiting

3 1 1 1
Investigated Diseases:
- Schizoaffective disorder
- Schizophrenia
Investigated Drugs:
- Olanzapine
Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Not recruiting

3 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
- Benralizumab
+7
Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
+3
Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Not recruiting

3 1 1
Investigated Drugs:
- Nivolumab
+9
Study on O15-Water for Diagnosing Coronary Artery Disease in Patients Using PET Imaging During Stress and Rest Conditions

Not recruiting

3 1 1
Investigated Drugs:
- O15-Water
Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
+1
Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Not recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies